Skip to content
OpenCapital
Get started

Agilon Health AGL AFS and Trading Securities - Unrealized Loss Position (>=12 Months)

AFS and Trading Securities - Unrealized Loss Position (>=12 Months) at other companies

CVS Health logo
CVS HealthCVS
——

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.78B-92.6%
Enterprise value$1.61B-103%
P/S0.3×-3.8×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%—

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio1×-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's afs and trading securities - unrealized loss position (>=12 months).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's AFS and trading securities - unrealized loss position (>=12 months)?
Agilon Health (AGL) reported AFS and trading securities - unrealized loss position (>=12 months) of $0 in Q4 2025.
How has Agilon Health's AFS and trading securities - unrealized loss position (>=12 months) changed year-over-year?
Agilon Health's AFS and trading securities - unrealized loss position (>=12 months) decreased by 100.0% year-over-year, from $111.92M to $0.
What is the long-term trend for Agilon Health's AFS and trading securities - unrealized loss position (>=12 months)?
Over 2 years (2023 to 2025), Agilon Health's AFS and trading securities - unrealized loss position (>=12 months) has grown at a -100.0% compound annual growth rate (CAGR), from $202.17M to $0.